National Center for Research Resources (NCRR): Mental Disorders trials
The registry lists 28 Mental Disorders studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 8Phase 3 9No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase I/II Study of Neuroendocrine Dysfunction in Patients With Closed Head InjuriesStatus unknownNCT00006271
- Study of the Approximate Entropy of Adrenocorticotropic Hormone and Cortisol Secretion in Patients With Head InjuryStatus unknownNCT00006270
- Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head InjuriesStatus unknownNCT00006128
- Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple SclerosisStatus unknownNCT00006060
- Genetic Study of Familial EpilepsyCompletedNCT00006059
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNCT00004939Phase 3
- A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple SclerosisCompletedNCT00004816Phase 1
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple SclerosisCompletedNCT00004814Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel DisordersCompletedNCT00004802Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut SyndromeCompletedNCT00004776Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00004772Phase 3
- Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron DiseaseCompletedNCT00004771Phase 2
- Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard TreatmentCompletedNCT00004758Phase 2
- Long-Term Study of Cerebral Glucose Metabolism in Huntington's DiseaseCompletedNCT00004753
- Phase II Study of Pallidotomy for Parkinson DiseaseCompletedNCT00004670Phase 2
- Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette SyndromeCompletedNCT00004652Phase 2
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic NeuropathyCompletedNCT00004647Phase 3
- Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular DystrophyCompletedNCT00004646Phase 3
- Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette SyndromeCompletedNCT00004393Phase 2
- Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's DiseaseCompletedNCT00004387Phase 2
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity DisorderCompletedNCT00004376Phase 3
- Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without AgoraphobiaCompletedNCT00004367Not applicable
- Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular DysfunctionCompletedNCT00004366Not applicable
- Study of the Neurobiology of Tourette Syndrome and Related DisordersCompletedNCT00004325
- Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and AdolescentsCompletedNCT00004324
- Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan DiseaseCompletedNCT00004314Phase 2
- Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive DisorderStatus unknownNCT00004310Phase 2
- Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3